Nautilus Biotechnology (NAUT) Selling, General & Administrative (2020 - 2026)
Nautilus Biotechnology (NAUT) Selling, General & Administrative (2020 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
SG&A (Qtr) |
| 1 |
Alterity Therapeutics |
788,338.31 Bn |
788,338.28 Bn |
- |
- |
| 2 |
Belite Bio |
56,560.00 Bn |
56,560.00 Bn |
- |
17.02 Mn |
| 3 |
Quantum Biopharma |
17,329.30 Bn |
17,329.30 Bn |
- |
1.32 Mn |
| 4 |
Legend Biotech |
3,341.00 Bn |
3,340.71 Bn |
242.10 Mn |
-37.00 Mn |
| 5 |
Akari Therapeutics |
1,727.91 Bn |
1,727.91 Bn |
- |
2.17 Mn |
| 6 |
Evaxion A |
1,536.68 Bn |
1,536.67 Bn |
- |
-1.52 Mn |
| 7 |
Psyence Biomedical |
238.34 Bn |
238.33 Bn |
- |
217,225.00 |
| 8 |
Vertex Pharmaceuticals |
113.42 Bn |
106.17 Bn |
2.59 Bn |
493.70 Mn |
| 9 |
Abivax |
95.45 Bn |
95.45 Bn |
- |
-7.36 Mn |
| 10 |
Nautilus Biotechnology |
298.22 Mn |
202.36 Mn |
- |
6.42 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
6.42 Mn |
| Dec 31, 2025 |
5.85 Mn |
| Sep 30, 2025 |
5.87 Mn |
| Jun 30, 2025 |
6.70 Mn |
| Mar 31, 2025 |
7.31 Mn |
| Dec 31, 2024 |
7.16 Mn |
| Sep 30, 2024 |
6.81 Mn |
| Jun 30, 2024 |
8.35 Mn |
| Mar 31, 2024 |
8.68 Mn |
| Dec 31, 2023 |
7.54 Mn |
| Sep 30, 2023 |
7.08 Mn |
| Jun 30, 2023 |
7.10 Mn |
| Mar 31, 2023 |
7.18 Mn |
| Dec 31, 2022 |
6.72 Mn |
| Sep 30, 2022 |
6.25 Mn |
| Jun 30, 2022 |
6.62 Mn |
| Mar 31, 2022 |
6.36 Mn |
| Dec 31, 2021 |
6.92 Mn |
| Sep 30, 2021 |
6.32 Mn |
| Jun 30, 2021 |
4.32 Mn |
